Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Browning West is an independent investment partnership based in Los Angeles, California, that employs a concentrated, long-term, and fundamental approach to investing. Founded in 2019 by Usman Nabi and Peter Lee, the firm focuses on identifying high-quality businesses in North America and Western Europe with the intent of holding investments for multiple years. Browning West is particularly known for its activist investment strategy, where it engages deeply with portfolio companies to drive operational excellence and long-term value creation. The firm has a significant focus on the healthcare and medical device sectors, maintaining major positions in companies such as The Cooper Companies and Somnigroup International (formerly Tempur Sealy). Through its activist campaigns, Browning West has successfully influenced board compositions and strategic directions, most notably in its high-profile proxy contest at Gildan Activewear. The partnership is backed by a select group of leading foundations, family offices, and university endowments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Browning West.